Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for RetinalGenix Technologies's Median PS Value or its related term are showing as below:
RTGN's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.715 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
RetinalGenix Technologies (OTCPK:RTGN) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
RetinalGenix Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
4.00
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RetinalGenix Technologies Median PS Value Related Terms
RetinalGenix Technologies Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RTGN vs SNWV, NNOX, LNSR: Median PS Value Comparison
For the Medical Devices subindustry, RetinalGenix Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RetinalGenix Technologies Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where RetinalGenix Technologies's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
RetinalGenix Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RetinalGenix Technologies (RTGN) has a Median PS Value of $0.00 as of Aug. 15, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on RetinalGenix Technologies and its competitors.
Is RetinalGenix Technologies' Median PS Value too high?
RetinalGenix Technologies' current Median PS Value is $0.00. Overall, RetinalGenix Technologies has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does RetinalGenix Technologies' Median PS Value compare to SNWV and NNOX?
RetinalGenix Technologies' Median PS Value of $0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.72, based on 334 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on RetinalGenix Technologies and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RetinalGenix Technologies's current Median PS Value is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RetinalGenix Technologies stock overvalued right now?
RetinalGenix Technologies (RTGN) has a current Median PS Value of $0.00. The current Median PS Value is $0.00. RetinalGenix Technologies' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For RetinalGenix Technologies (RTGN), the current Median PS Value is $0.00 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: Retinal Imaging Screening Device a portable, retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available.
30GF Score
Get the complete analysis for RTGN
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RTGN has been successfully added to your 
